THE POWER OF PSMA

Serial Number 79283785
Registration 6366701
700

Registration Progress

Application Filed
Mar 3, 2020
Under Examination
Approved for Publication
Mar 16, 2021
Published for Opposition
Mar 16, 2021
Registered
Jun 1, 2021

Trademark Image

THE POWER OF PSMA

Basic Information

Serial Number
79283785
Registration Number
6366701
Filing Date
March 3, 2020
Registration Date
June 1, 2021
Published for Opposition
March 16, 2021
Drawing Code
4000

Status Summary

Current Status
Active
Status Code
700
Status Date
Jun 1, 2021
Registration
Registered
Classes
005 010

Rights Holder

Telix Pharmaceuticals Limited

99
Address
Suite 401, 55 Flemington Road
North Melbourne VIC 3051
AU

Ownership History

Telix Pharmaceuticals Limited

Original Applicant
99
AU

Telix Pharmaceuticals Limited

Owner at Publication
99
AU

Telix Pharmaceuticals Limited

Original Registrant
99
AU

Legal Representation

Attorney
Andrew S. Ehard

USPTO Deadlines

Next Deadline
527 days remaining
Section 71 Declaration Due (Principal Register 66a) (Based on registration date 20210601)
Due Date
June 01, 2027
Grace Period Ends
December 01, 2027
Additional deadlines exist. Contact your attorney for complete deadline information.

Application History

32 events
Date Code Type Description Documents
Aug 14, 2022 NREP P NEW REPRESENTATIVE AT IB RECEIVED Loading...
Oct 11, 2021 FINO P FINAL DECISION TRANSACTION PROCESSED BY IB Loading...
Sep 22, 2021 FICS P FINAL DISPOSITION NOTICE SENT TO IB Loading...
Sep 21, 2021 FIMP P FINAL DISPOSITION PROCESSED Loading...
Sep 1, 2021 FICR P FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB Loading...
Jun 1, 2021 R.PR A REGISTERED-PRINCIPAL REGISTER Loading...
Mar 16, 2021 NPUB E OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED Loading...
Mar 16, 2021 PUBO A PUBLISHED FOR OPPOSITION Loading...
Mar 14, 2021 GPNX P NOTIFICATION PROCESSED BY IB Loading...
Feb 24, 2021 OPNS P NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB Loading...
Feb 24, 2021 OP2R P NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB Loading...
Feb 24, 2021 NONP E NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED Loading...
Feb 10, 2021 CNSA O APPROVED FOR PUB - PRINCIPAL REGISTER Loading...
Feb 9, 2021 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Feb 9, 2021 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Feb 9, 2021 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Oct 23, 2020 GNRN O NOTIFICATION OF NON-FINAL ACTION E-MAILED Loading...
Oct 23, 2020 GNRT O NON-FINAL ACTION E-MAILED Loading...
Oct 23, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
Sep 22, 2020 TEME I TEAS/EMAIL CORRESPONDENCE ENTERED Loading...
Sep 21, 2020 CRFA I CORRESPONDENCE RECEIVED IN LAW OFFICE Loading...
Sep 21, 2020 TROA I TEAS RESPONSE TO OFFICE ACTION RECEIVED Loading...
Jul 18, 2020 RFNT P REFUSAL PROCESSED BY IB Loading...
Jun 28, 2020 RFCS P NON-FINAL ACTION MAILED - REFUSAL SENT TO IB Loading...
Jun 28, 2020 RFRR P REFUSAL PROCESSED BY MPU Loading...
May 29, 2020 RFCR E NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW Loading...
May 28, 2020 CNRT R NON-FINAL ACTION WRITTEN Loading...
May 20, 2020 DOCK D ASSIGNED TO EXAMINER Loading...
May 2, 2020 MAFR O APPLICATION FILING RECEIPT MAILED Loading...
Apr 28, 2020 NWOS I NEW APPLICATION OFFICE SUPPLIED DATA ENTERED Loading...
Apr 27, 2020 LIMI I LIMITATION FROM ORIGINAL APPLICATION ENTERED Loading...
Apr 23, 2020 REPR M SN ASSIGNED FOR SECT 66A APPL FROM IB Loading...

Detailed Classifications

Class 005
Chemical preparations for pharmaceutical purposes, namely, diagnostic radiopharmaceutical preparations; pharmaceutical preparations for the imaging, diagnosing and monitoring of cancer; pharmaceutical preparations for the treatment of cancer; radiopharmaceutical imaging and detection agents for use in the imaging, diagnosing and monitoring of cancer; diagnostic kits comprising medical diagnostic radiopharmaceutical reagents and assays for testing of bodily fluids and tissue for use in detecting cancer and also consisting of vials, needleless drug delivery devices, swabable vial adaptors and medical syringes; drug delivery agents in the form of capsules that facilitate the delivery of pharmaceutical preparations; drug delivery agents in the form of capsules that provide controlled release of the active ingredients for a wide variety of pharmaceuticals
First Use Anywhere: 0
First Use in Commerce: 0
Class 010
Medical apparatus, namely, infusion and injection devices for administering drugs and diagnostic radiopharmaceuticals; medical apparatus for diagnostic radiopharmaceutical use; medical device for treating cancer; diagnostic imaging apparatus for medical use; applicators for pharmaceutical preparations, namely, drug delivery patches sold without medication
First Use Anywhere: 0
First Use in Commerce: 0

Classification

International Classes
005 010